Cargando…

Hospitalized patients received furosemide undergoing acute kidney injury: the risk and prediction tool

PURPOSE: Furosemide, a frequently prescribed diuretic for managing congestive heart failure and edema, remains a topic of debate regarding its potential risk of inducing acute kidney injury (AKI) in patients. Consequently, this study aims to examine the occurrence of hospital-acquired AKI (HA-AKI) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Chen, Li, Chenyu, Xu, Lingyu, Che, Lin, Wang, Yanfei, Yang, Chengyu, Zhang, Ningxin, Liu, Zengying, Zhao, Long, Zhou, Bin, Man, Xiaofei, Luan, Hong, Xu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474726/ https://www.ncbi.nlm.nih.gov/pubmed/37660080 http://dx.doi.org/10.1186/s40001-023-01306-0

Ejemplares similares

Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway
por: Guan, Chen, et al.
Publicado: (2023)

Tilianin Reduces Apoptosis via the ERK/EGR1/BCL2L1 Pathway in Ischemia/Reperfusion-Induced Acute Kidney Injury Mice
por: Liu, Zengying, et al.
Publicado: (2022)

Calycosin attenuates renal ischemia/reperfusion injury by suppressing NF-κB mediated inflammation via PPARγ/EGR1 pathway
por: Zhang, Ningxin, et al.
Publicado: (2022)

Acute kidney injury after nephrectomy: a new nomogram to predict postoperative renal function
por: Xu, Lingyu, et al.
Publicado: (2020)

A visual risk assessment tool for acute kidney injury after intracranial aneurysm clipping surgery
por: Zhang, Pei, et al.
Publicado: (2020)

Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
por: Liu, Zengying, et al.
Publicado: (2022)

Effect of continuous furosemide infusion on outcome of acute kidney injury
por: Ni, Jie, et al.
Publicado: (2019)

Serum response factor, a novel early diagnostic biomarker of acute kidney injury
por: Zhao, Long, et al.
Publicado: (2021)

Scutellarin Ameliorates Renal Injury via Increasing CCN1 Expression and Suppressing NLRP3 Inflammasome Activation in Hyperuricemic Mice
por: Li, Guozheng, et al.
Publicado: (2020)

Furosemide is associated with acute kidney injury in critically ill patients
por: Levi, T.M., et al.
Publicado: (2012)

Furosemide Stress Test in Predicting Acute Kidney Injury Outcomes
por: Rajasekaran, Kishore K, et al.
Publicado: (2020)

The furosemide stress test: Perspectives for acute kidney injury diagnosis
por: Hernández, Francisco J. López
Publicado: (2021)

Association between furosemide administration and outcomes in critically ill patients with acute kidney injury
por: Zhao, Guang-ju, et al.
Publicado: (2020)

Explainable machine learning model for predicting furosemide responsiveness in patients with oliguric acute kidney injury
por: Jiang, Meng, et al.
Publicado: (2023)

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment
por: Tanaka, Toshiki, et al.
Publicado: (2018)

Albumin and furosemide for acute lung injury
por: Khan, Asjad, et al.
Publicado: (2007)

Contribution of Uptake and Efflux Transporters to Oral Pharmacokinetics of Furosemide
por: Chapa, Revathi, et al.
Publicado: (2020)

Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease
por: Rivero, Jesús, et al.
Publicado: (2020)

Development and Standardization of a Furosemide Stress Test to Predict the Severity of Acute Kidney Injury
por: Chawla, Lakhmir S, et al.
Publicado: (2013)

Lack of furosemide responsiveness predict severe acute kidney injury after liver transplantation
por: Cai, Li, et al.
Publicado: (2023)

Association between serum uric acid levels and clinical outcomes in patients with acute kidney injury
por: Li, Xunliang, et al.
Publicado: (2023)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

Efficacy, Safety, and Tolerability of Oral Furosemide Among Patients Receiving Hemodialysis: A Pilot Study
por: Flythe, Jennifer E., et al.
Publicado: (2022)

Intermittent furosemide administration in patients with or at risk for acute kidney injury: Meta-analysis of randomized trials
por: Bove, Tiziana, et al.
Publicado: (2018)

Furosemide Stress Test and Renal Resistive Index for Prediction of Severity of Acute Kidney Injury in Sepsis
por: Das, Pravin K, et al.
Publicado: (2023)

Mesenchymal stem cells protect against sepsis-associated acute kidney injury by inducing Gal-9/Tim-3 to remodel immune homeostasis
por: Luo, Congjuan, et al.
Publicado: (2023)

Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide
por: Wang, Zhiyu, et al.
Publicado: (2020)

An NMR crystallography investigation of furosemide
por: Zilka, Miri, et al.
Publicado: (2018)

Furosemide: No effect: case report
Publicado: (2020)

Use of Oral Furosemide in Hemodialysis
por: Siga, Esteban, et al.
Publicado: (2022)

Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial
por: Barzegari, Hasan, et al.
Publicado: (2021)

Furosemide-induced pseudoporphyria in a patient with chronic kidney disease: case report
por: Pavanelli, Giovana Memari, et al.
Publicado: (2018)

Role of the Furosemide Stress Test in Renal Injury Prognosis
por: Coca, Armando, et al.
Publicado: (2020)

Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men
por: Rasmussen, Tyler P., et al.
Publicado: (2019)

The Effect of Furosemide on the Level of Neutrophil Gelatinase-associated Lipocalin in Critically Hospitalized Patients with Acute Kidney Injury
por: Hamishehkar, Hadi, et al.
Publicado: (2017)

Increased mortality in elderly heart failure patients receiving infusion of furosemide compared to elderly heart failure patients receiving bolus injection
por: Sager, Rana, et al.
Publicado: (2020)

Incidence and prognosis of acute kidney injury versus acute kidney disease among 71 041 inpatients
por: Xu, Lingyu, et al.
Publicado: (2023)

Furosemide, orlistat and non-steroidal anti-inflammatory agents—too much for the kidneys to handle!
por: Korzets, Asher, et al.
Publicado: (2009)

Liquisolid Systems to Improve the Dissolution of Furosemide
por: Akinlade, Babatunde, et al.
Publicado: (2010)

Temporal bone histopathology of furosemide ototoxicity
por: Santos, Felipe, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k9p0it6qh286vtoc6aucoj0osm